IRIS
PIERRI, IVANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.610
AS - Asia 905
NA - Nord America 480
SA - Sud America 55
AF - Africa 5
OC - Oceania 4
Totale 11.059
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.454
US - Stati Uniti d'America 451
SG - Singapore 400
CN - Cina 232
VN - Vietnam 148
FR - Francia 73
BD - Bangladesh 46
BR - Brasile 36
HK - Hong Kong 25
DE - Germania 18
FI - Finlandia 13
MX - Messico 11
GB - Regno Unito 10
NL - Olanda 10
CA - Canada 9
CH - Svizzera 9
AR - Argentina 7
IQ - Iraq 7
IN - India 6
JP - Giappone 6
UA - Ucraina 6
EC - Ecuador 5
ID - Indonesia 5
IE - Irlanda 4
TH - Thailandia 4
TR - Turchia 4
AU - Australia 3
IR - Iran 3
OM - Oman 3
PH - Filippine 3
PY - Paraguay 3
TW - Taiwan 3
AZ - Azerbaigian 2
DZ - Algeria 2
ES - Italia 2
GT - Guatemala 2
KE - Kenya 2
NI - Nicaragua 2
SA - Arabia Saudita 2
VE - Venezuela 2
AL - Albania 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
PF - Polinesia Francese 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
SE - Svezia 1
SV - El Salvador 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 11.059
Salva come PNG Salva come JPEG
Città #
Genova 6.153
Genoa 1.897
Rapallo 763
Vado Ligure 572
Singapore 188
San Jose 177
Lauterbourg 69
Ashburn 67
Ho Chi Minh City 45
New York 38
Hanoi 37
Beijing 30
Hong Kong 25
Bordighera 20
Frankfurt am Main 16
Santa Clara 14
Helsinki 13
Los Angeles 13
Da Nang 10
Zurich 9
Amsterdam 8
Mexico City 8
Milan 7
Rome 6
Biên Hòa 5
Haiphong 5
Montreal 5
Naples 5
Tokyo 5
Buffalo 4
Chicago 4
Dallas 4
Phoenix 4
Tianjin 4
Baghdad 3
Bắc Giang 3
Can Tho 3
Dublin 3
Kyiv 3
Newark 3
Orem 3
São Paulo 3
Torres 3
Turin 3
Bari 2
Basra 2
Boardman 2
Cardiff 2
Charlotte 2
Chennai 2
Cincinnati 2
City of London 2
Council Bluffs 2
Des Moines 2
Dhaka 2
Guatemala City 2
London 2
Lucca 2
Manchester 2
Nairobi 2
Ninh Bình 2
Nuremberg 2
Paris 2
Pasadena 2
Piscataway 2
Quito 2
Richmond 2
Riyadh 2
Seeb 2
Sydney 2
Taiyuan 2
Vĩnh Long 2
Wenzhou 2
Álvaro Obregón 2
Agadir 1
Aix-les-Bains 1
Amman 1
Ankara 1
Araucária 1
Araçatuba 1
Asunción 1
Athens 1
Atlanta 1
Augusta 1
Austin 1
Baltimore 1
Bangkok 1
Barbacena 1
Barretos 1
Belo Horizonte 1
Bento Gonçalves 1
Birigui 1
Blida 1
Blumenau 1
Blythe 1
Boca Raton 1
Boydton 1
Brampton 1
Brooklyn 1
Bắc Ninh 1
Totale 10.346
Salva come PNG Salva come JPEG
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 317
APO866 activity in hematologic malignancies: a preclinical in vitro study. 247
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 223
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse 213
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients 203
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 192
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages 191
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 188
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 177
Circadian variations of autologous mixed lymphocyte reactions and endogenous cortisol. 175
Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia. 173
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 173
Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors 171
T cells from patients with chronic liver diseases: abnormalities in PHA-induced expression of HLA class II antigens and in autologous mixed-lymphocyte reactions. 169
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia 168
First line therapy with Fludarabine combinations in 42 patients with either post-myelodysplastic syndrome or therapy related acute myeloid leukaemia. 168
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. 166
Evidence for killing of Mesenchymal Stem Cells (MSC) by autologous natural killer lymphocytes. 166
Analysis of the role of xenogeneic antigens in the proliferation of human T cells stimulated with autologous non-T cells and phytohemagglutinin-activated T cells. 165
Combination of liposomal Daunorubicin, Fludarabine, and Cytarabine (FLAD) in patients with poor- risk acute leukemia. 163
Abnormalities of T cells isolated from mediastinal lymph nodes and peripheral blood of patients with lung carcinoma: deficit in PHA-induced expression of HLA class II antigens and in autologous mixed lymphocyte reactions. 163
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 160
Thalidomide in agnogenic and secondary myelofibrosis 159
Essential Thrombocythemia: The Dermatologic Point of View 151
Molecular analysis of the Imatinib-induced complete cytogenetic response in chronic myelogenous leukemia 150
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 150
Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia 149
An unusual reaction to alpha interferon in a case of non Hodgkin's lymphoma. 148
Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells 147
Acute tuberculous septicemia. 147
Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicity. 145
Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia. 145
Human T lymphocytes in aging and malignancy: abnormalities in PHA-induced Ia antigen expression and in functional activity in autologous and allogeneic MLR. 144
Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis. 144
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: A feasible and effective salvage treatment for lymphoid malignancies 144
T-lymphocytes phenotype and functions in patients with head and neck cancer. 143
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 142
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients. 140
[Methods for studying pleiotropic drug resistance (multidrug resistance, MDR)]. 140
The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience. 138
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients 137
WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia. 134
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases 132
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. 131
In vivo apoptosis of CD8(+) lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-I and Fas ligand 128
Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders. 128
New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting. 128
Decreased lymphocyte blastogenesis, IL2 production and NK activity following nifedipine administration to healthy humans. 128
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party. 127
Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B 126
Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin’s lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation 125
Deficiency of the autologous mixed lymphocyte reactions of non-T/T and T/T type in intravenous drug abusers infected by the human immunodeficiency virus (HIV). 125
Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia. 123
[Remarks on rupture of the heart in recent myocardial infarct]. 122
PHA-T cells in systemic lupus erythematosus and in rheumatoid arthritis: abnormalities in HLA class II antigen induction and in autologous mixed lymphocyte reactions. 121
High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia. 116
Lymphocytapheresis in the treatment of rheumatoid arthritis: clinical and immunological studies. 116
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. 116
Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes. 116
Plasmaexchange plus immunoglobulins for treatment of hypergammaglobulinaemic patients with AIDS and AIDS-related complex (ARC). 113
Role of normal adherent cells in the regulation of the autologous mixed lymphocyte reactions in humans. 112
Human autologous mixed lymphocyte reactions (a review). 111
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates pro-apoptotic signals in chronic lymphocytic leukemia B cells 111
[Plasmacytoid lymphoma of the lung. Presentation of a case and review of the literature]. 107
In vitro enhancement of the proliferative response of human T cells to autologous non-T cells by hydralazine. 106
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia. 104
Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens. 103
Seventeen years of experience with ATRA-based therapy for acute promyelocytic leukaemia: long-term follow-up of patients treated at S. Martino Hospital, Genoa 101
Expression of HLA-class II antigens and proliferative capacity in autologous mixed lymphocyte reactions of human T lymphocytes exposed in vitro to alpha-endorphin. 100
GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly. 99
[Granulomatous giant-cell endometritis due to talc]. 99
CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells cdan be targeted with ligands to induce apoptosis 98
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase. 94
Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method. 92
Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment? 89
Thiol containing antioxidant drugs and the human immune system. 86
Decreased sensitivity of T lymphocytes to normal adherent suppressor cells in patients with head and neck cancer. 85
GM-IVA, a short induction course for de novo acute myeloid leukemia, suitable for the elderly. 85
Immunocompetence in lung cancer patients: analysis of serological and cellular parameters. 79
Totale 11.110
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.738
article - articoli 31.738
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.476
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 0 0 51
2021/2022943 27 73 48 111 30 60 77 206 34 88 36 153
2022/2023939 109 72 16 103 166 168 5 67 155 1 71 6
2023/2024485 27 62 8 51 45 111 24 23 20 7 30 77
2024/20251.344 19 106 41 78 210 151 111 206 40 69 152 161
2025/20262.138 272 47 66 149 301 213 390 101 199 212 137 51
Totale 11.110